12:00 AM
Aug 19, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

CPX-351: Clinical trial started

Celator said investigators at the Fred Hutchinson Cancer Research Center began an open-label clinical trial to evaluate 32 and 64 units/m 2 IV CPX-351 in up to...

Read the full 122 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >